Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and absorption study of RO7795074 administration forms in overweight or obese healthy adults
NL-OMON59600Phase 1Completed
- Sponsor
- Genentech
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of CT-996, sponsored by Genentech. Started Dec 2025; status: completed.
02
Drugs
CT-996
Beyond the preview
Go deeper on NL-OMON59600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59600.